Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C33H43N5O5 |
Molecular Weight | 589.725 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N3C(=O)[C@](NC(=O)[C@H]4CN(C)[C@]5([H])CC6=C(C)NC7=C6C(=CC=C7)C5=C4)(O[C@@]23O)C(C)C
InChI
InChIKey=AFFLEALSHYGOOD-NOURLPFCSA-N
InChI=1S/C33H43N5O5/c1-17(2)13-26-30(40)37-12-8-11-27(37)33(42)38(26)31(41)32(43-33,18(3)4)35-29(39)20-14-23-21-9-7-10-24-28(21)22(19(5)34-24)15-25(23)36(6)16-20/h7,9-10,14,17-18,20,25-27,34,42H,8,11-13,15-16H2,1-6H3,(H,35,39)/t20-,25-,26+,27+,32-,33+/m1/s1
Molecular Formula | C33H43N5O5 |
Molecular Weight | 589.725 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Mergocriptine (2-methyl-a-ergocryptine or CBM36-733) is a synthetic long-acting ergot derivative. It exerts agonistic action at dopamine receptors. Mergocryptine may induce the suppression of striatal dopamine turnover by reducing dopamine release via the stimulation of presynaptic dopaminergic autoreceptors. In animal experiments, it may affect cerebral hemodynamics. Mergocriptine has a protective effect on the brain against ischemia.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2077182
Curator's Comment: Mergocriptine is CNS active in animals. No human data available.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:55:21 GMT 2023
by
admin
on
Fri Dec 15 18:55:21 GMT 2023
|
Record UNII |
VXD47YRH4Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
54803
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
DTXSID501002339
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
SUB08775MIG
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
100000081711
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
VXD47YRH4Q
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105887
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
C170163
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
81968-16-3
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY | |||
|
5762
Created by
admin on Fri Dec 15 18:55:21 GMT 2023 , Edited by admin on Fri Dec 15 18:55:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |